Basic Information
LncRNA/CircRNA Name | DICER1-AS1 |
Synonyms | NA |
Region | GRCh38_14:95157645-95179933 |
Ensemble | ENSG00000235706 |
Refseq | NR_015415 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | autophagy | Drug | ||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | osteosarcoma |
ICD-0-3 | NA |
Methods | Microarray, qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP |
Sample | osteosarcoma cell lines (MG-63, U2OS, HOS, 143B, Saos-2) |
Expression Pattern | up-regulated |
Function Description | DICER1-AS1 was up-regulated in osteosarcoma cells using microarray analysis and RT-PCR. Cellular functional experiments revealed that DICER1-AS1 knockdown suppressed the proliferation, migration, invasion and autophagy of osteosarcoma cells in vitro. Besides, DICER1-AS1 knockdown inhibited the protein expression levels of ATG5, LC3-II and Beclin 1, suggesting the inhibition on the autophagy of osteosarcoma cells. Moreover, miR-30b was verified to target 3'-UTR of DICER1-AS1 and ATG5 using bioinformatics tools and luciferase reporter assay or RNA-immunoprecipitation (RIP). Western blot showed that ATG5 protein expression was decreased in DICER1-AS1 knockdown and miR-30b mimics transfected cells, while increased in miR-30b inhibitor transfected cells, presenting a negative correlation with miR-30b and a positive correlation with DICER1-AS1. Finally, xenograft assay in vivo indicated that DICER1-AS1 knockdown inhibited the osteosarcoma tumor growth and protein expression level of ATG5. |
Pubmed ID | 29772430 |
Year | 2018 |
Title | LncRNA DICER1-AS1 Promotes the Proliferation, Invasion and Autophagy of Osteosarcoma Cells via miR-30b/ATG5 |
External Links
Links for DICER1-AS1 | GenBank HGNC NONCODE |
Links for osteosarcoma | OMIM COSMIC |